Switch to Global Market

Lithuanian Market Community

Our community narratives are driven by numbers and valuation.

Lithuanian Investing Ideas

Global Weekly Picks

CUE logo
Cue Biopharma

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Cue Biopharma bets its future on a new allergy drug designed by the same scientist who created Xolair, aiming to make treatment far less frequent for people with chronic hives and other allergic conditions. A key mid-stage trial result is coming soon, and it could either put Cue on big pharma’s radar or expose just how risky this turnaround really is.
View narrative
US$70
FV
61.3% undervalued intrinsic discount
1.2k
users have viewed this narrative
7users have liked this narrative
0users have commented on this narrative
31users have followed this narrative
ADBE logo
Adobe

Adobe: A Probabilistic Case for Undervaluation

Adobe sits in the middle of the AI disruption debate, but the view here is that rivals will struggle to unseat it as the default toolset for creative and marketing work anytime soon. The key question is whether the market is overreacting to new AI tools and missing how sticky Adobe’s products and customer habits remain.
View narrative
US$319.96
FV
31.6% undervalued intrinsic discount
8.88%
Revenue growth p.a.
2.8k
users have viewed this narrative
14users have liked this narrative
8users have commented on this narrative
38users have followed this narrative
OKTA logo
Okta

Good foundation, but now it's all about the next steps

Okta now reaches profitability, but the bigger question is whether its CEO can turn that milestone into steady, lasting profit as customer loyalty slips. The story hinges on new pricing, added services, and even a possible tie-up with CrowdStrike to unlock the next phase.
View narrative
US$151
FV
22.2% undervalued intrinsic discount
10.50%
Revenue growth p.a.
5.1k
users have viewed this narrative
11users have liked this narrative
7users have commented on this narrative
87users have followed this narrative
ROE1L logo
AB Artea bankas

Modernization Fund And Fee Expansion Will Support Stronger Future Earnings Power

Catalysts About AB Artea bankas AB Artea bankas is a Lithuanian bank that provides lending, deposit, asset management, renovation financing and capital markets services to retail and corporate clients. What are the underlying business or industry changes driving this perspective?Read more

View narrative
€1.4
37.2% undervalued intrinsic discount
Fair Value
Revenue
-1.01% p.a.
Profit Margin
51.48%
Future PE
10.69x
Price in 2029
€1.78
ROE1L logo
AB Artea bankas

Core Banking Replatforming And Housing Renovation Fund Will Support Steady Long Term Performance

Catalysts About AB Artea bankas AB Artea bankas is a Lithuanian bank focused on corporate and retail lending, fee based services and investment products. What are the underlying business or industry changes driving this perspective?Read more

View narrative
€0.89
1.2% undervalued intrinsic discount
Fair Value
Revenue
-6.23% p.a.
Profit Margin
44.51%
Future PE
9.25x
Price in 2029
€1.13
ROE1L logo
AB Artea bankas

Rising High-Value Credit Demand And Cost Efficiencies Will Support Stronger Bank Earnings Resilience

Catalysts About AB Artea bankas AB Artea bankas is a Lithuania focused universal bank providing retail, corporate, and asset management services, underpinned by a growing digital and capital markets platform. What are the underlying business or industry changes driving this perspective?Read more

View narrative
€1.03
15.1% undervalued intrinsic discount
Fair Value
Revenue
-3.64% p.a.
Profit Margin
44.37%
Future PE
10.04x
Price in 2028
€1.32
IGN1L logo
AB Ignitis grupe

Green Generation Expansion And Battery Storage Are Expected To Drive Long Term Upside

Catalysts About AB Ignitis grupe AB Ignitis grupe is an integrated utility focused on developing and operating green generation, electricity networks, reserve capacities and customer energy solutions across the Baltics and Poland. What are the underlying business or industry changes driving this perspective?Read more

View narrative
€27.2
22.2% undervalued intrinsic discount
Fair Value
Revenue
5.21% p.a.
Profit Margin
8.98%
Future PE
9.63x
Price in 2028
€34.47